M. L. Alegre, K. A. Frauwirth, and C. B. Thompson, T-cell regulation by CD28 and CTLA-4, Nat Rev Immunol, vol.1, issue.3, pp.220-228, 2001.

P. J. Leibson, The regulation of lymphocyte activation by inhibitory receptors, Curr Opin Immunol, vol.16, issue.3, pp.328-336, 2004.

T. L. Walunas, D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman et al., CTLA-4 can function as a negative regulator of T cell activation, Immunity, vol.1994, issue.5, p.90071

M. Bonelli, E. Ferner, L. Goschl, S. Bluml, A. Hladik et al., Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis, Arthritis Rheum, vol.65, issue.3, pp.599-607, 2012.

M. Bonelli, L. Goschl, S. Bluml, T. Karonitsch, K. Hirahara et al., Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis, Rheumatology (Oxford), vol.55, issue.4, pp.710-720

U. Fiocco, P. Sfriso, F. Oliviero, E. Pagnin, E. Scagliori et al., Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept, Autoimmun Rev, vol.8, issue.1, pp.76-82, 2008.

A. Patakas, R. R. Ji, W. Weir, S. E. Connolly, R. A. Benson et al., Abatacept Inhibition of T Cell Priming in Mice by Induction of a Unique Transcriptional Profile That Reduces Their Ability to Activate Antigen-Presenting Cells, Arthritis Rheumatol, vol.68, issue.3, pp.627-638, 2015.

M. H. Buch, D. L. Boyle, S. Rosengren, B. Saleem, R. J. Reece et al., Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study, Ann Rheum Dis, vol.68, issue.7, pp.1220-1227, 2009.

P. H. Remans, C. A. Wijbrandts, M. E. Sanders, R. E. Toes, F. C. Breedveld et al., CTLA-4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells, Arthritis Rheum, vol.54, issue.10, pp.3135-3143, 2006.

M. A. D'agostino, M. Boers, R. J. Wakefield, B. Hammer, H. Vittecoq et al., Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE study, RMD Open, vol.2016, issue.1

M. A. D'agostino, R. J. Wakefield, H. Berner-hammer, O. Vittecoq, G. Filippou et al., Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study, Ann Rheum Dis, vol.75, issue.10, pp.1763-1769, 2016.

F. C. Arnett, S. M. Edworthy, D. A. Bloch, D. J. Mcshane, J. F. Fries et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, vol.31, issue.3, pp.315-324, 1988.

D. M. Van-der-heijde, M. A. Van't-hof, P. L. Van-riel, L. A. Theunisse, E. W. Lubberts et al., Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score, Ann Rheum Dis, vol.49, issue.11, pp.916-920, 1990.

C. Derambure, G. Dzangue-tchoupou, C. Berard, N. Vergne, M. Hiron et al., Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis, Arthritis Res Ther, vol.19, issue.1, p.28545499, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02337207

K. Keeren, M. Friedrich, I. Gebuhr, S. Philipp, R. Sabat et al., Expression of tolerance associated gene-1, a mitochondrial protein inhibiting T cell activation, can be used to predict response to immune modulating therapies, J Immunol, vol.183, issue.6, pp.4077-4087, 2009.

T. S. Randall, C. Moores, and F. A. Stephenson, Delineation of the TRAK binding regions of the kinesin-1 motor proteins, FEBS Lett, vol.587, issue.23, pp.3763-3769, 2013.

M. J. Wozniak, M. Melzer, C. Dorner, H. U. Haring, and R. Lammers, The novel protein KBP regulates mitochondria localization by interaction with a kinesin-like protein, BMC Cell Biol, vol.6, p.35, 2005.

I. Lopez-fabuel, L. Douce, J. Logan, A. James, A. M. Bonvento et al., Complex I assembly into supercomplexes determines differential mitochondrial ROS production in neurons and astrocytes, Proc Natl Acad Sci, vol.113, issue.46, pp.13063-13068, 2016.

M. Pavel, S. Imarisio, F. M. Menzies, M. Jimenez-sanchez, F. H. Siddiqi et al., CCT complex restricts neuropathogenic protein aggregation via autophagy, Nat Commun, vol.7, p.13821, 2016.

Z. Yang, Y. Shen, H. Oishi, E. L. Matteson, L. Tian et al., Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis, Sci Transl Med, vol.8, issue.331, pp.331-338, 2016.

S. Nakamura, K. Suzuki, H. Iijima, Y. Hata, C. R. Lim et al., Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study, Arthritis Res Ther, vol.18, p.27435242, 2016.

D. Radtke, S. M. Lacher, N. Szumilas, L. Sandrock, J. Ackermann et al., Grb2 Is Important for T Cell Development, Th Cell Differentiation, and Induction of Experimental Autoimmune Encephalomyelitis, J Immunol, vol.196, issue.7, pp.2995-3005, 2016.

K. Wang, L. H. Diao, Y. Gong, X. Liu, and Y. Li, NEMO differentially regulates TCR and TNF-alpha induced NF-kappaB pathways and has an inhibitory role in TCR-induced NF-kappaB activation, Cell Signal, vol.24, issue.8, pp.1556-1564

S. A. O'brien, M. Zhu, and W. Zhang, The Importance of IL-6 in the Development of LAT-Mediated Autoimmunity, J Immunol, vol.195, issue.2, pp.695-705, 2015.

M. M. Maurice, A. C. Lankester, A. C. Bezemer, M. F. Geertsma, P. P. Tak et al., Defective TCRmediated signaling in synovial T cells in rheumatoid arthritis, J Immunol, vol.159, issue.6, pp.2973-2978, 1997.

N. Sakaguchi, T. Takahashi, H. Hata, T. Nomura, T. Tagami et al., Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice, Nature, vol.426, issue.6965, pp.454-460, 2003.

J. G. Egen, M. S. Kuhns, and J. P. Allison, CTLA-4: new insights into its biological function and use in tumor immunotherapy, Nat Immunol, vol.3, issue.7, pp.611-618, 2002.

T. Yao and A. Ndoja, Regulation of gene expression by the ubiquitin-proteasome system, Semin Cell Dev Biol, vol.2012, issue.5, pp.523-529

X. Saelens, N. Festjens, L. Vande-walle, M. Van-gurp, G. Van-loo et al., Toxic proteins released from mitochondria in cell death, Oncogene, vol.23, issue.16, pp.2861-2874, 2004.

Y. Mazaki, S. Hashimoto, and H. Sabe, Monocyte cells and cancer cells express novel paxillin isoforms with different binding properties to focal adhesion proteins, J Biol Chem, vol.272, issue.11, pp.7437-7444, 1997.

C. Ding, J. Luo, X. Fan, L. Li, S. Li et al., Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels, J Exp Clin Cancer Res, vol.2017, issue.1, p.28420432